D. M. Strickland, MD, FACOG and J. Sorboro, MD, DABPN, FASAM, “Adverse effects of regulation on buprenorphine prescribing and its impact on the treatment of opioid use disorder”, J of Opioid Management, vol. 17, no. 7, pp. 133–139, Aug. 2021.